The results of the traditional karyotyping and of FISH and M-FISH assays on metaphase nuclei reported in this study highlight that complex structural alterations of Chr17 encompassing the HER2 gene and CEP17 are common in breast cancer cell lines. Here, ERBB2 is linked to breast cancer.